Finland
· Delayed Price · Currency is EUR Nightingale Health Oyj Statistics
Total Valuation
Nightingale Health Oyj has a market cap or net worth of EUR 165.33 million. The enterprise value is 101.93 million.
| Market Cap | 165.33M |
| Enterprise Value | 101.93M |
Important Dates
The next estimated earnings date is Thursday, March 6, 2025.
| Earnings Date | Mar 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Nightingale Health Oyj has 60.34 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 60.34M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 28.25% |
| Owned by Institutions (%) | 7.48% |
| Float | 34.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 38.30 |
| PB Ratio | 1.99 |
| P/TBV Ratio | 2.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.84 |
| EV / Sales | 23.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -9.60 |
Financial Position
The company has a current ratio of 9.84, with a Debt / Equity ratio of 0.03.
| Current Ratio | 9.84 |
| Quick Ratio | 9.70 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.25 |
| Interest Coverage | -1,687.18 |
Financial Efficiency
Return on equity (ROE) is -19.38% and return on invested capital (ROIC) is -12.35%.
| Return on Equity (ROE) | -19.38% |
| Return on Assets (ROA) | -11.74% |
| Return on Capital (ROIC) | -12.35% |
| Revenue Per Employee | 50,674 |
| Profits Per Employee | -203,058 |
| Employee Count | 86 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 2.33 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +149.09% in the last 52 weeks. The beta is 0.64, so Nightingale Health Oyj's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | +149.09% |
| 50-Day Moving Average | 3.02 |
| 200-Day Moving Average | 2.39 |
| Relative Strength Index (RSI) | 40.41 |
| Average Volume (20 Days) | 61,980 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nightingale Health Oyj had revenue of EUR 4.36 million and -17.46 million in losses. Loss per share was -0.29.
| Revenue | 4.36M |
| Gross Profit | 2.90M |
| Operating Income | -18.56M |
| Pretax Income | -17.38M |
| Net Income | -17.46M |
| EBITDA | -14.06M |
| EBIT | -18.56M |
| Loss Per Share | -0.29 |
Balance Sheet
The company has 66.04 million in cash and 2.64 million in debt, giving a net cash position of 63.40 million or 1.05 per share.
| Cash & Cash Equivalents | 66.04M |
| Total Debt | 2.64M |
| Net Cash | 63.40M |
| Net Cash Per Share | 1.05 |
| Equity (Book Value) | 82.88M |
| Book Value Per Share | 1.37 |
| Working Capital | 61.48M |
Cash Flow
In the last 12 months, operating cash flow was -8.41 million and capital expenditures -2.21 million, giving a free cash flow of -10.62 million.
| Operating Cash Flow | -8.41M |
| Capital Expenditures | -2.21M |
| Free Cash Flow | -10.62M |
| FCF Per Share | -0.18 |
Margins
| Gross Margin | 66.45% |
| Operating Margin | -425.86% |
| Pretax Margin | -398.69% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Nightingale Health Oyj does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -10.46% |
| FCF Yield | -6.42% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Nightingale Health Oyj has an Altman Z-Score of 4.64.
| Altman Z-Score | 4.64 |
| Piotroski F-Score | n/a |